Your email has been successfully added to our mailing list.

×
0.00215672178289009 0.00323508267433501 -0.0107836089144501 -0.00280373831775699 -0.0035945363048166 -0.00287562904385328 -0.00143781452192664 -0.00287562904385328
Stock impact report

TG Therapeutics launches newly approved multiple sclerosis therapy [Seeking Alpha]

TG Therapeutics, Inc. (TGTX) 
Last tg therapeutics, inc. earnings: 11/12 07:34 am Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
Company Research Source: Seeking Alpha
TG Therapeutics launches newly approved multiple sclerosis therapyJan. 26, 2023 8:13 AM ETTG Therapeutics, Inc. ()By:Dulan LokuwithanaSA News Editor1 Commentkoto_fejaâ??We have built what we consider to be a best-in-class team to support this launch, as well as a robust patient support program designed to aid in accessing BRIUMVI at all points through the treatment journey,â? CEO of Show less Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
TGTX alerts

from News Quantified
Opt-in for
TGTX alerts

from News Quantified